Wall Street set to decline on surging coronavirus infections By Reuters
By Sruthi Shankar
(Reuters) – Futures pointed to a weak start for Wall Street’s main indexes on Thursday on fears that soaring COVID-19 cases will stifle growth in the world’s largest economy.
The S&P 500 index () was set for its third straight session of losses, retreating further from an all-time high hit on Monday after positive data was released on a coronavirus vaccine.
The U.S. death toll from COVID-19 surpassed a grim new milestone of 250,000 on Wednesday as New York City’s schools called a halt to in-classroom instruction, the latest in restrictions to curb the spread of the virus.
While trillions of dollars in stimulus and optimism around a vaccine have driven Wall Street to record highs following a coronavirus-driven crash in March, investors are wary of the near-term damage caused by tightening restrictions and in the absence of fresh stimulus measures.
All eyes will be on the Labor Department’s weekly jobless claims data due at 8:30 a.m. ET. Claims are expected to edge down to 707,000 in the week ended Nov. 14, from 709,000 in the week before.
At 6:56 a.m. ET, were down 68 points, or 0.23%,
L Brands Inc (N:) surged 16.1% premarket after posting better-than-expected quarterly results, helped by record sales growth at Bath & Body Works and higher demand for Victoria’s Secret lingerie.
Department store operator Macy’s Inc (N:) fell 4% after it reported a more than 20% fall in third-quarter comparable sales.
Nvidia Corp (O:) slipped 1.3% after company executives said data center chip sales would fall slightly in the fourth quarter.
Fusion Media or anyone involved with Fusion Media will not accept any liability for loss or damage as a result of reliance on the information including data, quotes, charts and buy/sell signals contained within this website. Please be fully informed regarding the risks and costs associated with trading the financial markets, it is one of the riskiest investment forms possible.